Search Within

Mark Kris

Formats
  1. Journal Article (480)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (872)
  2. Solid Tumor Oncology Division (872)
  3. Thoracic Oncology (872)
  4. Department of Pathology and Laboratory Medicine (319)
  5. GSK Faculty (292)
  6. Human Oncology and Pathogenesis Program (225)

More Groups

People
  1. Gregory Riely (222)
  2. Marc Ladanyi (190)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (123)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (7)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (25)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (48)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (872)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Piloting IBM Watson Oncology within Memorial Sloan Kettering's regional network
    Meeting Abstract

    Zauderer, M. G.; Gucalp, A.; Epstein, A. S.; Seidman, A. D.; Caroline, A.; Granovsky, S.; Fu, J.; Keesing, J.; Lewis, S.; Co, H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Stage at diagnosis as a prognostic marker for patients with KRAS-mutant metastatic lung adenocarcinomas
    Meeting Abstract

    Yu, H. A.; Hellmann, M. D.; Sima, C. S.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • HER2 mutations in lung adenocarcinoma: A report from the Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Pillai, R. N.; Behera, M.; Berry, L. D.; Rossi, M. R.; Kris, M. G.; Bunn, P. A.; Khuri, F. R.; Ramalingam, S. S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC
    Meeting Abstract

    Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Wakelee, H. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • NEOSCAN: Phase II trial of neoadjuvant chemotherapy for resectable lung cancers with switch to chemo alternative in (18)F-FDG PET nonresponders
    Meeting Abstract

    Kris, M. G.; Hellmann, M. D.; Naidoo, J.; Dunphy, M.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Chaft, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and prognostic impact of MET receptor overexpression in patients with stage I-IIIA squamous cell lung carcinomas (SQCLCs)
    Meeting Abstract

    Hellmann, M. D.; Anderson, T. A.; Eng, J.; Sima, C. S.; Kris, M. G.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next steps for IBM Watson Oncology: Scalability to additional malignancies
    Meeting Abstract

    Epstein, A. S.; Zauderer, M. G.; Gucalp, A.; Seidman, A. D.; Caroline, A.; Fu, J.; Keesing, J.; Hsiao, F.; Megerian, M.; Eggebraaten, T.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save